期刊文献+

依那普利联合吲达帕胺治疗高血压的临床疗效

The Clinical Curative effect of Enalapril and Indapamide in Treatment of Essential Hypertension
原文传递
导出
摘要 目的探讨依那普利联合吲达帕胺治疗高血压的临床疗效。方法收集我院2013年1月至2014年3月收治的60例高血压患者资料,将患者按随机数字表法分为试验组和对照组,各30例,对照组患者给予依那普利治疗,试验组患者在其基础上联合吲达帕胺治疗。比较两组患者的临床疗效。结果试验组患者治疗总有效率为93.3%,明显高于对照组的80.0%,且不良反应发生率也低于对照组,差异均有统计学意义(均P<0.05)。结论依那普利联合吲达帕胺治疗高血压患者具有良好的疗效。 Objective To investigate the clinical efficacy of enalapril and indapamide in treatment of essential hypertension.Methods Choose 60 cases of hypertension patients in our hospital from 2013 January to 2014 March were as the object of study, the patients were randomly divided into experimental group and control group,each 30 cases,patients in control group were treated with enalapril treatment,patients in experimental group on the basis of combined with indapamide in the treatment.Comparison of two groups of patients with clinical efficacy.Results In the test group the total effective rate was 93.3%,significantly higher than 80.0% in the control group,and the incidence of adverse events was tower than that of the control group,the difference was statistically significant(P〈0.05). Conclusion Have a good curative effect of enalapril and indapamide in the treatment of patients with hypertension.
出处 《中国药物经济学》 2015年第5期85-86,共2页 China Journal of Pharmaceutical Economics
关键词 高血压 依那普利 吲达帕胺 Hypertension Enalaprilat Indapamide
  • 相关文献

参考文献5

二级参考文献32

  • 1顾东风,Jiang He,吴锡桂,段秀芳,姚崇华,王家良,Kristi Reynolds,Chung-Shiuan Chen,Michael J.Klag,Paul K.Whelton.中国成年人主要死亡原因及其危险因素[J].中国慢性病预防与控制,2006,14(3):149-154. 被引量:75
  • 2高璐,于德民,靳建鸣.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂联合治疗糖尿病肾病的临床研究[J].中国糖尿病杂志,2006,14(3):205-207. 被引量:14
  • 3简桂花,崔勇平,盛晓华,高许萍,汪年松.双倍剂量氯沙坦治疗糖尿病肾病蛋白尿疗效评价[J].中国临床医学,2007,14(1):92-93. 被引量:10
  • 4Mattock MB,Morrish NJ,Viberti G,et al.Prospective study of microalbu-minuria as predictor of mortality in NIDDM[J].Diabetes,1992;41(6):736-41.
  • 5Segurs J,Ruilope LM,Rodicio JL.Microalbuminuria[J].Clin Exp Hy-pertens,2004;25(728):701-7.
  • 6Czekalski S.Diabetic nephropathy and cardiovascular diseases[J].Rocz Akad Med Bialymst,2005;50(2):122.
  • 7Mogensen CE,Schmitz O.The diabetic kidney:from hypertension and mi-croalbuminuria to end-stage renal failure[J].Med Clin North Am,1998;72(6):1465-92.
  • 8Brenner BM,Cooper ME,Dick de Zeeuw,et al.Effects of losartan on re-nal and cardiovascular outcomes in patients with type 2 diabetes and ne-phropathy[J].N Engl J Med,2001;345(12):861-9.
  • 9Koh K K, Park S M, Quon M J. Leptin and cardiovascular disease. Response to therapeutic intervention[ J]. Circulation ,2008,117:3238.
  • 10Smith C C, Mocanu M M, Leptin, the obesity-associated cardioprotective effects[ J]. Br (1) :5. Davidson S M, et al. hormone, exhibits direct J Pharmacol, 2006, 149.

共引文献501

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部